10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
GILEAD SCIENCES, INC. | ||
Ticker: GILD Fiscal Year: 2011 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2011 10-K (Filed: Feb 23, 2012) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2011 | Dec 31, 2010 | |
| Assets | ||
| Cash and cash equivalents | $ 9,883,777 | 907,879 |
| Short-term marketable securities | 16,491 | 1,190,789 |
| Accounts receivable, net of allowances of $205,990 at December 31, 2011 and $150,942 at December 31, 2010 | 1,951,167 | 1,621,966 |
| Inventories | 1,389,983 | 1,203,809 |
| Deferred tax assets | 208,155 | 279,339 |
| Prepaid taxes | 246,444 | 320,424 |
| Prepaid expenses | 95,922 | 67,632 |
| Other current assets | 126,846 | 116,244 |
| Total current assets | 13,918,785 | 5,708,082 |
| Property, plant and equipment, net | 774,406 | 701,235 |
| Noncurrent portion of prepaid royalties | 174,584 | 203,790 |
| Noncurrent deferred tax assets | 144,015 | 153,379 |
| Long-term marketable securities | 63,704 | 3,219,403 |
| Intangible assets | 2,066,966 | 1,425,592 |
| Other noncurrent assets | 160,674 | 181,149 |
| Total assets | 17,303,134 | 11,592,630 |
| Liabilities and Stockholders' Equity | ||
| Accounts payable | 1,206,052 | 803,025 |
| Accrued government rebates | 516,045 | 325,018 |
| Accrued compensation and employee benefits | 173,316 | 147,632 |
| Income taxes payable | 40,583 | 1,862 |
| Other accrued liabilities | 502,557 | 437,893 |
| Deferred revenues | 74,665 | 103,175 |
| Current portion of convertible senior notes, net and other long-term obligations | 1,572 | 646,345 |
| Total current liabilities | 2,514,790 | 2,464,950 |
| Long-term deferred revenues | 31,870 | 32,844 |
| Long-term debt, net | 7,605,734 | 2,838,573 |
| Long-term income taxes payable | 135,655 | 107,025 |
| Other long-term obligations | 147,736 | 27,401 |
| Commitments and contingencies (Note 12) | ||
| Stockholders' equity: | ||
| Preferred stock, par value $0.001 per share; 5,000 shares authorized; none outstanding | 0 | 0 |
| Common stock, par value $0.001 per share; 2,800,000 shares authorized; 753,106 and 801,998 shares issued and outstanding at December 31, 2011 and 2010, respectively | 753 | 802 |
| Additional paid-in capital | 4,903,143 | 4,648,286 |
| Accumulated other comprehensive income | 58,200 | 30,911 |
| Retained earnings | 1,776,760 | 1,183,730 |
| Total Gilead stockholders' equity | 6,738,856 | 5,863,729 |
| Noncontrolling interest | 128,493 | 258,108 |
| Total stockholders' equity | 6,867,349 | 6,121,837 |
| Total liabilities and stockholders' equity | 17,303,134 | 11,592,630 |
| External Links | |
| GILEAD SCIENCES, INC. (GILD) Fiscal Year 2011 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |